Clinical Trial Update: Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated bendamustine plus ofatumumab in elderly patients with newly diagnosed diffuse large B-cell lymphoma who are poor candidates f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Ofatumumab (ofatumumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-10-18